The long-term mortality and morbidity of cardiac transplant recipients is related to their subsequent development of accelerated coronary atheroma and its complications. Coronary angiography was compared with non-invasive clinical assessment to see which was better in predicting clinical outcome. Ninety-one consecutive transplant recipients (mean age 53 years), in whom investigations had been performed (exercise electrocardiography, rest and exercise radionuclide ventriculography, 2-D echocardiography and coronary angiography), were followed up for a mean period of 21 years. Eighteen patients had 31 cardiac events. There were five cardiac-related deaths, 17 myocardial infarctions and/or onsets of heart failure, eight percutaneous transluminal coronary angioplasties and one coronary artery bypass graft. With cardiac event-free survival as the dependent variable and the results of the above investigations as independent variables, a series of univariate, bivariate and regression analyses were performed. On bivariate analysis, an echocardiographic ejection fraction of >60% significantly predicted both survival free of myocardial infarction and/or heart failure and/or cardiac death and survival free of any cardiac event (/ ) =0001 for both). Absence of coronary angiographic disease (both of <25% and of <50% luminal narrowing in any vessel) significantly predicted survival free of any cardiac event (/>=000004 and 0015, respectively). Neither radionuclide ventriculography nor exercise electrocardiography were significant predictors of event free survival.
Introduction
Accelerated coronary sclerosis is a specific form of coronary arterial disease. It is one of the main determinants of the medium and long term results of cardiac transplantation, both in terms of mortality and morbidity. The incidence increases progressively to 20-45% by 3 years [1 " 101 . The disease causes episodic and sustained myocardial ischaemia and may progress rapidly 1 "" 13 '. Accelerated coronary sclerosis presents an important clinical problem for the foreseeable future. As cardiac denervation results in silent ischaemia with atypical clinical presentation, frequent cardiac investigation becomes necessary. Conventional non-invasive methods, commonly used to screen for ischaemic heart disease, such as exercise electrocardiography, thallium scintigraphy and two dimensional echocardiography, are thought to be relatively insensitive in detecting accelerated coronary sclerosis. Currently, the diagnosis is made by routine angiography, which in many centres is performed annually. However, this procedure tends to underestimate the presence and/or severity of the disease [l4J5] . Although patients who develop angiographic evidence of accelerated coronary sclerosis have a 3-5 fold increased incidence of cardiac events including myocardial infarction, heart failure and sudden death' 81 , the course of the disease varies considerably between patients. Appropriate diagnosis and identification of patients at high risk of developing cardiac events is essential for the prevention and management of this condition.
The aim of the present study is to investigate the prognostic value of routine non-invasive cardiological tests, such as exercise electrocardiography, radionuclide ventriculography and two-dimensional echocardiography compared to coronary angiography in predicting cardiac events in cardiac transplant recipients.
Patients and methods
Over a one-year period, all 91 consecutive cardiac transplant recipients, who had been followed routinely 0195 Two-dimensional echocardiography was performed with a Hewlett Packard Sonos 1000 System, using a 2-5 MHz transducer. The ejection fraction was derived from cubed systolic and diastolic short axis measurements obtained by M-mode at the time of two-dimensional echocardiography. All patients underwent right-and left-sided cardiac catheterization using the femoral approach, with left ventricular and selective coronary angiography. Diagnosis of accelerated coronary sclerosis was made when luminal reduction of at least 25% was confirmed by angiography in any segment of the four major epicardial coronary arteries. The two reviewers who reported the angiographic results were unaware of the clinical state of the patients.
The following clinical outcomes were measured: acute myocardial infarction, onset of heart failure, cardiac related death and myocardial revascularization (percutaneous transluminal coronary angioplasty) and/ or coronary artery bypass grafting. For clinical diagnosis of myocardial infarction the following criteria were adopted: electrocardiographic changes in at least two leads with sequential increase in cardiac enzymes with or without chest pain. Survival time was measured from the date at which the full set of non-invasive tests (exercise electrocardiography, resting and exercise radionuclide ventriculography and two-dimensional echocardiography) were first performed at the time of routine annual coronary angiography to onset of any cardiac event. By grouping clinical events, two dependent variables were created: (a) event-free survival time until either acute myocardial infarction, onset of heart failure or cardiac death, and (b) event-free survival time until either acute myocardial infarction, onset of heart failure, or myocardial revascularization. The electrocardiographic, radionuclide ventriculographic, echocardiographic and angiographic findings were analysed as independent predictor variables, having been categorized as follows. Exercise electrocardiography was classified as positive if there was 1 mm ST depression 130 ms after the J point. Radionuclide ventriculography was considered abnormal if it measured the left ventricular ejection fraction as less than 60%. This threshold was applied both to the resting and to the exercise radionuclide ventriculogram. Two-dimensional echocardiograms were dichotomized into those which gave the left ventricular ejection fraction as less than 60% and those which gave it as equal to or greater than 60%. (Preliminary analysis of the echocardiographic data indicated that a left ventricular ejection fraction value of 60% provided a suitably discriminate cut-off point.) Coronary angiograms were analysed using two different dichotomies. The first classified angiograms as positive if one or more of the major epicardial coronary arteries had a maximum percentage stenosis of 25% or more and negative if all major coronary arteries had maximum percentage stenosis of less than 25%. The second dichotomy was similar except that it used an angiographic stenosis of 50% or more as its cut-off point.
A series of univariate and multivariate descriptive analyses were performed, followed by a series of Kaplan-Meier survival curves, in which each of the categorized independent variables described above was plotted against both of the dependent variables. Survival analysis was performed using the Kaplan-Meier product limit estimator of event-free survival and the logrank test.
Finally, regression analysis using the categorized independent variables in a series of Cox proportional hazards models was performed, with outcome (b) (any cardiac event, including coronary revascularization) as the dependent variable.
Results
Ninety-one patients (80 men and 11 women), mean age 53-5 and 51-2 years, respectively, were followed up for a =at least one >=25% at angiography.
-=all mean of 212 years (1-2-402 years). Nine patients died, five from cardiac causes, two from non-cardiac causes and in two the exact cause was not ascertained. Eighteen patients had 31 cardiac events (four myocardial infarctions, 13 onsets of heart failure, eight percutaneous transluminal coronary angioplasties, one coronary artery bypass graft and five cardiac deaths). Table 1 summarises the logrank tests of the Kaplan-Meier plots of the six independent variables against survival time to any cardiac event. It demonstrates that, on serial bivariate analysis, echocardiographic left ventricular ejection fractions of <60% and angiographic disease (using either the >25% or >50% threshold) were both significant predictors of reduced cardiac event-free survival. Neither radionuclide ventriculography nor exercise electrocardiography were significant predictors of event-free survival. The KaplanMeier survival curves of outcome to any cardiac event, plotted for echocardiographic left ventricular ejection fraction and for angiographic disease are displayed in Figs 1-3 . Table 2 demonstrates the odds ratios and P-values obtained for the independent variables by regression analysis, with outcome (b) (any cardiac event, including coronary revascularization) as the dependent variable. Although there was no significant evidence that more than one variable should be included in the model, multivariate analysis using both angiographic disease 25% and echocardiographic left ventricular ejection fraction 60% as independent variables in the same model was performed: the odds ratios and /'-values from these are shown in Table 3 . =at least one > = 50% at angiography.
-=all 
Discussion
Due to the rising number of cardiac transplants performed and improving survival rate' 16 ', an increasing number of transplant recipients require medical follow-up to detect the presence of accelerated coronary sclerosis, its rate of progression and most importantly its clinical relevance as defined by its effect on outcome. The non-invasive tests commonly available for the detection of native coronary artery disease are considered insensitive' 17 " 191 . It has been reported that dobutamine stress echocardiography is a feasible non-invasive method for the surveillance and diagnosis of patients with functionally important accelerated coronary sclerosis' 20 '. The same report also showed that evidence of accelerated coronary sclerosis can be demonstrated by intracoronary ultrasound and dobutamine stress echocardiography in patients with normal angiographic findings. Furthermore, Ciliberto et a/.' 21 ', reported that high dose dipyridamole stress echocardiography is useful for defining patients with severe lesions (more than 50%). More recently our group reported that coronary calcification detected by ultrafast computed tomography scanning is a marker of accelerated coronary sclerosis' 22 '. However, none of these studies investigated the prognostic value of these tests in predicting cardiac events. Exercise electrocardiography, radionuclide ventriculography and echocardiography are performed routinely on cardiac transplant recipients in many centres, yet reports on their clinical value have been few. To date, the only study on predicting cardiac events was by Urtesky et a/.' 8 ' who showed that angiographic evidence of accelerated coronary sclerosis defined a high risk patient group for subsequent cardiac events. However, conventional coronary angiography underestimates the extent and severity of accelerated coronary sclerosis, as illustrated by the fact that 28% of patients who had cardiac events showed no angiographic evidence of accelerated coronary sclerosis'
81
. Moreover coronary angiography is an invasive and expensive procedure and an increasing number of patients are reluctant to undertake it annually. This study demonstrated that an echocardiographic ejection fraction of more than 60% predicted both survival free of myocardial infarction or heart failure, and also survival free of any cardiac event (/•=0001 for both). It also demonstrated that absence of coronary angiographic disease (both of 25% and 50% luminal narrowing in any vessel) predicted survival free of any cardiac event (/>=000004 and 0015, respectively). The apparent poor outcome for those patients with stenosis between 25% and 50% indicate that it is the minor coronary disease that is more predictive of adverse clinical outcome than more severe disease. The other tests such as exercise electrocardiography and radionuclide ventriculography) did not predict eventfree survival. We also demonstrated that on regression analysis echocardiographic ejection fraction of >60% and absence of coronary angiographic disease of >25% luminal narrowing in any one vessel were the only significant independent predictors of any cardiac event.
The measurement of left ventricular ejection fraction with M-mode echocardiography has been used for many years despite obvious limitation when there is segmental dysfunction' 23 " 251 . Furthermore, the majority of clinicians measure the ejection fraction as a means of evaluating left ventricular function in patients with coronary artery disease.
This study has served to identify several noninvasive parameters where both, alone and in combination with angiography, could act as important predictors of cardiac events. The limitation of this study is the relatively small number of patients and events. In spite of that, several possible predictors of clinical outcome have been identified. This should be further tested in a separate large group for validation. Furthermore, the combination of impaired left ventricular function and abnormal coronary angiogram may define a high risk group suitable for investigating new treatment modalities.
In summary, echocardiographic ejection fraction can be used to predict cardiac events in cardiac transplant recipients and complement angiographic data in this subset of patients.
